insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

DRTS · Alpha Tau Medical Ltd. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · DRTS

Sign in to download
AnnualQuarterly

Income Statement

Line itemQ4 '25Q2 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22Q4 '21Q4 '20Q4 '19
Revenue----------
Cost of Revenue----------
Gross Profit----------
R&D----------
SG&A----------
Total Operating Expenses----------
D&A----------
Operating Income----------
Interest Expense----------
Income Tax----------
Net Income----------
EPS - Basic----------
EPS - Diluted----------

Balance Sheet

Line itemQ4 '25Q2 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22Q4 '21Q4 '20Q4 '19
Cash & Equivalents$12.20M$11.70M$13.72M$2.76M$12.66M$855.0K$5.84M$23.24M$15.60M$1.84M
Accounts Receivable----------
Inventory----------
Accounts Payable$3.87M$2.40M$3.53M$2.57M$2.57M$1.79M$1.42M$1.20M$964.0K-
Current Assets$78.30M$85.78M$64.23M$75.25M$85.76M$96.06M$106.48M$32.64M$47.45M-
Total Assets$105.65M$110.95M$86.20M$96.05M$107.39M$111.21M$120.15M$42.22M$52.99M-
Current Liabilities$10.51M$8.16M$8.68M$6.46M$7.10M$5.42M$4.34M$4.41M$2.09M-
Long-term Debt----$5.2K-----
Total Liabilities$28.55M$24.33M$23.54M$22.03M$22.91M$18.64M$14.49M$23.03M$7.45M-
Stockholders' Equity$77.10M$86.62M$62.67M$74.02M$84.47M$92.56M$105.66M($34.78M)($8.43M)($193.0K)
Retained Earnings($190.14M)($166.31M)($147.51M)($131.11M)($115.76M)($103.48M)($86.60M)($52.84M)($25.57M)-

Cash Flow

Line itemQ4 '25Q2 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22Q4 '21Q4 '20Q4 '19
Operating Cash Flow----------
Investing Cash Flow----------
Financing Cash Flow----------
CapEx----------
Free Cash Flow----------

Ratios

MetricQ4 '25Q2 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22Q4 '21Q4 '20Q4 '19
Profitability
Gross margin----------
Operating margin----------
EBITDA margin----------
Net margin----------
Free cash flow margin----------
FCF / Net income----------
R&D / Revenue----------
SG&A / Revenue----------
Effective tax rate----------
Return on assets----------
Return on equity----------
Return on invested capital----------
Liquidity
Current ratio7.4510.527.4011.6612.0717.7424.557.4122.73-
Quick ratio7.4510.527.4011.6612.0717.7424.557.4122.73-
Cash ratio1.161.431.580.431.780.161.355.277.47-
Leverage
Debt / Equity----0.00-----
Debt / Assets----0.00-----
Debt / EBITDA----------
Interest coverage----------
Equity multiplier1.371.281.381.301.271.201.14-1.21-6.29-
Liabilities / Assets0.270.220.270.230.210.170.120.550.14-
Efficiency
Asset turnover----------
Inventory turnover----------
Days sales outstanding----------
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E----------
P / B----------
P / S----------
EV / EBITDA----------
Growth
Revenue growth (YoY)----------
Revenue CAGR (3y)----------
Revenue CAGR (5y)----------
Gross profit growth (YoY)----------
Operating income growth (YoY)----------
Net income growth (YoY)----------
EPS growth (YoY)----------
EPS CAGR (3y)----------
EPS CAGR (5y)----------
FCF growth (YoY)----------
FCF CAGR (5y)----------
Book value growth (YoY)23.0%17.0%-25.8%-20.0%-20.0%---312.6%-4267.4%-

Peer comparison

Same SIC group: Surgical & Medical Instruments & Apparatus

CompanyRevenue (last FY)Net marginROE
BSX$20.07B14.4%12.0%
LMAT$249.60M23.1%14.7%
TNDM$1.01B-20.2%-131.9%
SYK$25.12B12.9%14.5%
MMM$24.95B13.0%69.1%

Comparing Alpha Tau Medical Ltd. against the 5 most active filers in the same SIC group.